Weight-loss drugs reshape UK shopping habits, reducing grocery spend

Created at 8 Jul · 12:40 AM1 source↑ Market-relevant

IN SHORT

Weight-loss medications like Wegovy and Mounjaro are altering consumer spending in the UK, with users spending significantly less on groceries and dining out. Research indicates a shift towards healthier food choices and products addressing medication side effects, though the high cost of these drugs is a major factor in users discontinuing treatment.

Key Numbers

2 millionUK users of weight-loss medications

£418Average annual grocery savings per household with GLP-1 user

£780mEstimated national reduction in grocery spending

5%US grocery spending reduction within six months for users

8%US grocery spending reduction for higher-income families

10%Reduction in spending on savoury snacks by US users

8%Decline in spending at fast-food chains and coffee shops in US research

£300Monthly cost of weight-loss drug prescriptions in the UK

Who's Involved

Worldpanel by Numerator

Market research company that studied UK grocery spending habits

Cornell University

Conducted peer-reviewed study on US households' spending changes

Nishita Pattni

Senior consultant at Worldpanel by Numerator

Zava

Online doctor and pharmacy service that surveyed weight-loss drug users

↳ Why This Matters

The widespread adoption of weight-loss drugs is creating ripple effects across consumer markets, impacting grocery sales, the food service industry, and the demand for personal care products. This shift in spending patterns has significant implications for businesses and economic forecasting.

Key facts

Households using weight-loss drugs spent an average of £418 less on groceries annually.
Users reduced spending on processed foods, snacks, and dining out, opting for healthier alternatives.
Purchases of products addressing side effects like hair dye and mouthwash increased.
Nearly two-thirds of users cut back on eating out.
The high cost of medication is the main reason users stop treatment.
Grocery spending patterns return to normal, or even less healthy, after discontinuing medication.

Weight-loss medications such as Wegovy and Mounjaro, which mimic the hormone GLP-1 to regulate appetite, are significantly altering consumer spending habits in the UK. Research indicates that households with at least one user of these drugs spent approximately £418 less on groceries annually compared to non-users, contributing to an estimated national reduction of £780 million in grocery spending.

This trend aligns with a Cornell University study finding that US households with weight-loss drug users reduced grocery spending by 5% within six months, with higher-income families seeing an 8% decrease. The research highlights a shift in purchasing patterns, with users buying less calorie-dense processed foods, chocolate, pastries, and alcohol, and more fruits and protein-rich items. Additionally, spending on items that counteract common side effects like hair thinning and bad breath, such as hair dye and mouthwash, has increased.

Spending on eating out has also been impacted, with nearly two-thirds of surveyed UK users cutting back or reducing meals out. Cornell's research noted an 8% decline in spending at fast-food chains and coffee shops. Worldpanel suggests users are adopting a more 'mindful' approach to eating, guided by hunger cues. However, the substantial cost of these medications, which can exceed £300 per month in the UK, is a significant barrier, with cost being the primary reason cited by users for discontinuing treatment. Studies also indicate that grocery spending patterns tend to revert to pre-adoption levels, or even shift towards less healthy choices, once medication is stopped.

Frequently asked questions

These medications mimic a natural hormone, GLP-1, which helps regulate hunger and reduces appetite.

Users tend to spend less on processed foods, snacks, and sugary items, and more on fruits and protein-rich foods.

Products like chewing gum, mouthwash, and hair dyes have seen increased purchases to counter side effects such as bad breath and thinning hair.

The high cost of the medication is the number one reason people stop taking it.

What Happens Next

01Further research may explore long-term impacts on consumer behavior and specific industry revenues.

02Discussions on drug affordability and accessibility are likely to continue.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

CME Headlines

10-Year T-Note futures fell as yields hit multi-week highs
7 Jul · 9:43 PM
10-Year T-Note futures fell as yields hit multi-week highs
7 Jul · 9:43 PM
Euro futures fell as Middle East headlines broke narrow range.
7 Jul · 8:04 PM

How It Developed

Weight-loss medications have surged in popularity, with over two million people in the UK now using them.

Households with GLP-1 users spent an average of £418 less on groceries annually compared to non-users.

US households with weight-loss drug users spent 5% less on groceries within six months, rising to 8% for higher-income families.

Users reduced spending on chocolate, pastries, savoury snacks, alcohol, and dining out, while increasing purchases of fruit, protein-rich foods, and products like chewing gum and hair dye.

Nearly two-thirds of Worldpanel survey respondents reported cutting back on meals out.

Cornell research found an 8% decline in spending at fast-food chains and coffee shops.

The high cost of the drugs, often exceeding £300 per month, is the primary reason users stop taking them.

Spending patterns revert to pre-adoption levels, and even shift towards less healthy baskets, when medication is discontinued.

Sources

From mouthwash to hair dye: How weight-loss jabs are changing shopping habitsBBC News